Cargando…

Acupuncture as an Adjunctive Treatment for Post-stroke Epilepsy: Protocol for a Randomized Controlled Trial

Background: Acupuncture has been clinically used to treat epilepsy after stroke. However, most of the current clinical studies are observational studies, and there are few well-designed randomized controlled trials (RCTs). Hence, we designed a multicentre RCT to assess the advantages and efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yang, Zhao, Meidan, Zhang, Baozhen, Zhang, Kai, Zhou, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427139/
https://www.ncbi.nlm.nih.gov/pubmed/34512522
http://dx.doi.org/10.3389/fneur.2021.711390
_version_ 1783750131624968192
author Zhang, Yang
Zhao, Meidan
Zhang, Baozhen
Zhang, Kai
Zhou, Zhen
author_facet Zhang, Yang
Zhao, Meidan
Zhang, Baozhen
Zhang, Kai
Zhou, Zhen
author_sort Zhang, Yang
collection PubMed
description Background: Acupuncture has been clinically used to treat epilepsy after stroke. However, most of the current clinical studies are observational studies, and there are few well-designed randomized controlled trials (RCTs). Hence, we designed a multicentre RCT to assess the advantages and efficacy of acupuncture for post-stroke epilepsy (PSE). Methods/Design: This is a two-arm, parallel, participants-blinded and assessor-blinded and multicentre RCT. A total of 120 patients with PSE aged from 18 to 75 years will be randomly assigned to two groups (routine treatment plus acupuncture group and routine treatment plus sham acupuncture group) at a 1:1 ratio. The participants will perform acupuncture or sham acupuncture treatment three times a week and be ongoing 8-week treatment. The primary endpoint is the proportion of seizure-free patients. A safety profile will be established. We will record adverse events for the safety evaluation. Discussion: The study will provide high-quality clinical evidence on the effectiveness and safety of acupuncture for treating patients with epilepsy after stroke. Clinical Trial Registration: Chinese Clinical Trial Registry, identifier: ChiCTR2100046114.
format Online
Article
Text
id pubmed-8427139
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84271392021-09-10 Acupuncture as an Adjunctive Treatment for Post-stroke Epilepsy: Protocol for a Randomized Controlled Trial Zhang, Yang Zhao, Meidan Zhang, Baozhen Zhang, Kai Zhou, Zhen Front Neurol Neurology Background: Acupuncture has been clinically used to treat epilepsy after stroke. However, most of the current clinical studies are observational studies, and there are few well-designed randomized controlled trials (RCTs). Hence, we designed a multicentre RCT to assess the advantages and efficacy of acupuncture for post-stroke epilepsy (PSE). Methods/Design: This is a two-arm, parallel, participants-blinded and assessor-blinded and multicentre RCT. A total of 120 patients with PSE aged from 18 to 75 years will be randomly assigned to two groups (routine treatment plus acupuncture group and routine treatment plus sham acupuncture group) at a 1:1 ratio. The participants will perform acupuncture or sham acupuncture treatment three times a week and be ongoing 8-week treatment. The primary endpoint is the proportion of seizure-free patients. A safety profile will be established. We will record adverse events for the safety evaluation. Discussion: The study will provide high-quality clinical evidence on the effectiveness and safety of acupuncture for treating patients with epilepsy after stroke. Clinical Trial Registration: Chinese Clinical Trial Registry, identifier: ChiCTR2100046114. Frontiers Media S.A. 2021-08-26 /pmc/articles/PMC8427139/ /pubmed/34512522 http://dx.doi.org/10.3389/fneur.2021.711390 Text en Copyright © 2021 Zhang, Zhao, Zhang, Zhang and Zhou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Zhang, Yang
Zhao, Meidan
Zhang, Baozhen
Zhang, Kai
Zhou, Zhen
Acupuncture as an Adjunctive Treatment for Post-stroke Epilepsy: Protocol for a Randomized Controlled Trial
title Acupuncture as an Adjunctive Treatment for Post-stroke Epilepsy: Protocol for a Randomized Controlled Trial
title_full Acupuncture as an Adjunctive Treatment for Post-stroke Epilepsy: Protocol for a Randomized Controlled Trial
title_fullStr Acupuncture as an Adjunctive Treatment for Post-stroke Epilepsy: Protocol for a Randomized Controlled Trial
title_full_unstemmed Acupuncture as an Adjunctive Treatment for Post-stroke Epilepsy: Protocol for a Randomized Controlled Trial
title_short Acupuncture as an Adjunctive Treatment for Post-stroke Epilepsy: Protocol for a Randomized Controlled Trial
title_sort acupuncture as an adjunctive treatment for post-stroke epilepsy: protocol for a randomized controlled trial
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427139/
https://www.ncbi.nlm.nih.gov/pubmed/34512522
http://dx.doi.org/10.3389/fneur.2021.711390
work_keys_str_mv AT zhangyang acupunctureasanadjunctivetreatmentforpoststrokeepilepsyprotocolforarandomizedcontrolledtrial
AT zhaomeidan acupunctureasanadjunctivetreatmentforpoststrokeepilepsyprotocolforarandomizedcontrolledtrial
AT zhangbaozhen acupunctureasanadjunctivetreatmentforpoststrokeepilepsyprotocolforarandomizedcontrolledtrial
AT zhangkai acupunctureasanadjunctivetreatmentforpoststrokeepilepsyprotocolforarandomizedcontrolledtrial
AT zhouzhen acupunctureasanadjunctivetreatmentforpoststrokeepilepsyprotocolforarandomizedcontrolledtrial